Literature DB >> 23040584

Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study.

Nir Uriel1, Kerry A Morrison, Arthur R Garan, Tomoko S Kato, Melana Yuzefpolskaya, Farhana Latif, Susan W Restaino, Donna M Mancini, Margaret Flannery, Hiroo Takayama, Ranjit John, Paolo C Colombo, Yoshifumi Naka, Ulrich P Jorde.   

Abstract

OBJECTIVES: This study sought to develop a novel approach to optimizing continuous-flow left ventricular assist device (CF-LVAD) function and diagnosing device malfunctions.
BACKGROUND: In CF-LVAD patients, the dynamic interaction of device speed, left and right ventricular decompression, and valve function can be assessed during an echocardiography-monitored speed ramp test.
METHODS: We devised a unique ramp test protocol to be routinely used at the time of discharge for speed optimization and/or if device malfunction was suspected. The patient's left ventricular end-diastolic dimension, frequency of aortic valve opening, valvular insufficiency, blood pressure, and CF-LVAD parameters were recorded in increments of 400 rpm from 8,000 rpm to 12,000 rpm. The results of the speed designations were plotted, and linear function slopes for left ventricular end-diastolic dimension, pulsatility index, and power were calculated.
RESULTS: Fifty-two ramp tests for 39 patients were prospectively collected and analyzed. Twenty-eight ramp tests were performed for speed optimization, and speed was changed in 17 (61%) with a mean absolute value adjustment of 424 ± 211 rpm. Seventeen patients had ramp tests performed for suspected device thrombosis, and 10 tests were suspicious for device thrombosis; these patients were then treated with intensified anticoagulation and/or device exchange/emergent transplantation. Device thrombosis was confirmed in 8 of 10 cases at the time of emergent device exchange or transplantation. All patients with device thrombosis, but none of the remaining patients had a left ventricular end-diastolic dimension slope >-0.16.
CONCLUSIONS: Ramp tests facilitate optimal speed changes and device malfunction detection and may be used to monitor the effects of therapeutic interventions and need for surgical intervention in CF-LVAD patients.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23040584      PMCID: PMC3545519          DOI: 10.1016/j.jacc.2012.07.052

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

1.  Imaging of left ventricular device complications.

Authors:  Vincent M Mellnick; Demetrios A Raptis; Constantine Raptis; Sanjeev Bhalla
Journal:  J Thorac Imaging       Date:  2013-03       Impact factor: 3.000

2.  Utilization of cardiac computed tomography angiography for the diagnosis of left ventricular assist device thrombosis.

Authors:  Joseph D Mishkin; Jonathan R Enriquez; Dan M Meyer; Brian T Bethea; Jennifer T Thibodeau; Parag C Patel; David W Markham; Pradeep P A Mammen; Mariella Velez-Martinez; Mark H Drazner
Journal:  Circ Heart Fail       Date:  2012-03-01       Impact factor: 8.790

3.  Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial.

Authors:  Ranjit John; Yoshifumi Naka; Nicholas G Smedira; Randall Starling; Ulrich Jorde; Peter Eckman; David J Farrar; Francis D Pagani
Journal:  Ann Thorac Surg       Date:  2011-10       Impact factor: 4.330

4.  Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.

Authors:  Soon J Park; Carmelo A Milano; Antone J Tatooles; Joseph G Rogers; Robert M Adamson; D Eric Steidley; Gregory A Ewald; Kartik S Sundareswaran; David J Farrar; Mark S Slaughter
Journal:  Circ Heart Fail       Date:  2012-01-26       Impact factor: 8.790

5.  Echocardiography can be more sensitive than thoracic computed tomography in detecting a thrombus in the inflow cannula of a continuous left ventricular assist device.

Authors:  Nadia Aissaoui; Lech Paluszkiewicz; Heinrich H Koertke; Michiel Morshuis; Jan Gummert
Journal:  Echocardiography       Date:  2011-08-19       Impact factor: 1.724

6.  Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.

Authors:  Yan Topilsky; Tal Hasin; Jae K Oh; Daniel D Borgeson; Barry A Boilson; John A Schirger; Alfredo L Clavell; Robert P Frantz; Rayji Tsutsui; Mingya Liu; Simon Maltais; Sudhir S Kushwaha; Naveen L Pereira; Soon J Park
Journal:  Circ Cardiovasc Imaging       Date:  2011-09-21       Impact factor: 7.792

7.  Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device.

Authors:  Masaru Hatano; Koichiro Kinugawa; Taro Shiga; Naoko Kato; Miyoko Endo; Motoyuki Hisagi; Takashi Nishimura; Atsushi Yao; Yasunobu Hirata; Shunei Kyo; Minoru Ono; Ryozo Nagai
Journal:  Circ J       Date:  2011-03-03       Impact factor: 2.993

8.  Use of a continuous-flow device in patients awaiting heart transplantation.

Authors:  Leslie W Miller; Francis D Pagani; Stuart D Russell; Ranjit John; Andrew J Boyle; Keith D Aaronson; John V Conte; Yoshifumi Naka; Donna Mancini; Reynolds M Delgado; Thomas E MacGillivray; David J Farrar; O H Frazier
Journal:  N Engl J Med       Date:  2007-08-30       Impact factor: 91.245

9.  Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.

Authors:  Francis D Pagani; Leslie W Miller; Stuart D Russell; Keith D Aaronson; Ranjit John; Andrew J Boyle; John V Conte; Roberta C Bogaev; Thomas E MacGillivray; Yoshifumi Naka; Donna Mancini; H Todd Massey; Leway Chen; Charles T Klodell; Juan M Aranda; Nader Moazami; Gregory A Ewald; David J Farrar; O Howard Frazier
Journal:  J Am Coll Cardiol       Date:  2009-07-21       Impact factor: 24.094

10.  pROC: an open-source package for R and S+ to analyze and compare ROC curves.

Authors:  Xavier Robin; Natacha Turck; Alexandre Hainard; Natalia Tiberti; Frédérique Lisacek; Jean-Charles Sanchez; Markus Müller
Journal:  BMC Bioinformatics       Date:  2011-03-17       Impact factor: 3.307

View more
  63 in total

1.  Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device.

Authors:  Michael E Nassif; Jayendrakumar S Patel; Jerrica E Shuster; David S Raymer; Ronald Jackups; Eric Novak; Brian F Gage; Sunil Prasad; Scott C Silvestry; Gregory A Ewald; Shane J LaRue
Journal:  JACC Heart Fail       Date:  2015-02       Impact factor: 12.035

Review 2.  Remote monitoring for better management of LVAD patients: the potential benefits of CardioMEMS.

Authors:  Jesse F Veenis; Jasper J Brugts
Journal:  Gen Thorac Cardiovasc Surg       Date:  2020-01-24

Review 3.  Pump thrombosis-A riddle wrapped in a mystery inside an enigma.

Authors:  Arie Blitz
Journal:  Ann Cardiothorac Surg       Date:  2014-09

4.  Diagnosis and Management of LVAD Thrombosis.

Authors:  Edo Y Birati; J Eduardo Rame
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-02

Review 5.  Highlights of the year in JACC 2012.

Authors:  Anthony N DeMaria; Jeroen J Bax; Gregory K Feld; Barry H Greenberg; Jennifer L Hall; Mark A Hlatky; Wilbur Y W Lew; João A C Lima; Ehtisham Mahmud; Alan S Maisel; Sanjiv M Narayan; Steven E Nissen; David J Sahn; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2013-01-22       Impact factor: 24.094

Review 6.  Impact of adverse events on ventricular assist device outcomes.

Authors:  Aleksandar Adzic; Snehal R Patel; Simon Maybaum
Journal:  Curr Heart Fail Rep       Date:  2013-03

7.  Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist Devices: Results From the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).

Authors:  Veli K Topkara; A Reshad Garan; Barry Fine; Amandine F Godier-Furnémont; Alexander Breskin; Barbara Cagliostro; Melana Yuzefpolskaya; Koji Takeda; Hiroo Takayama; Donna M Mancini; Yoshifumi Naka; Paolo C Colombo
Journal:  Circ Heart Fail       Date:  2016-07       Impact factor: 8.790

8.  Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device.

Authors:  Deepak K Gupta; Hicham Skali; Jose Rivero; Patricia Campbell; Leslie Griffin; Colleen Smith; Courtney Foster; Brian Claggett; Robert J Glynn; Gregory Couper; Michael M Givertz; Mandeep R Mehra; Marcelo Di Carli; Scott D Solomon; Marc A Pfeffer
Journal:  J Heart Lung Transplant       Date:  2014-01-27       Impact factor: 10.247

9.  Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates.

Authors:  Teruhiko Imamura; Valluvan Jeevanandam; Gene Kim; Jayant Raikhelkar; Nitasha Sarswat; Sara Kalantari; Bryan Smith; Daniel Rodgers; Stephanie Besser; Ben Chung; Ann Nguyen; Nikhil Narang; Takeyoshi Ota; Tae Song; Colleen Juricek; Mandeep Mehra; Maria Rosa Costanzo; Ulrich P Jorde; Daniel Burkhoff; Gabriel Sayer; Nir Uriel
Journal:  Circ Heart Fail       Date:  2019-02       Impact factor: 8.790

Review 10.  Expanding the Scope of Multimodality Imaging in Durable Mechanical Circulatory Support.

Authors:  Zaid I Almarzooq; Anubodh S Varshney; Muthiah Vaduganathan; Manan Pareek; Garrick C Stewart; Jerry D Estep; Mandeep R Mehra
Journal:  JACC Cardiovasc Imaging       Date:  2019-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.